Company registration number 10218146 (England and Wales)
HEALTHCALL SOLUTIONS LIMITED
FINANCIAL STATEMENTS
FOR THE PERIOD ENDED 31 MARCH 2025
PAGES FOR FILING WITH REGISTRAR
HEALTHCALL SOLUTIONS LIMITED
CONTENTS
Page
Balance sheet
1
Notes to the financial statements
2 - 8
HEALTHCALL SOLUTIONS LIMITED
BALANCE SHEET
AS AT
31 MARCH 2025
31 March 2025
- 1 -
2025
2023 - unaudited
Notes
£
£
£
£
Fixed assets
Intangible assets
3
1,089,377
1,330,999
Tangible assets
4
1,533
Investments
5
1
1
1,089,378
1,332,533
Current assets
Stocks
-
19,920
Debtors
6
203,032
426,632
Cash at bank and in hand
232,036
297,297
435,068
743,849
Creditors: amounts falling due within one year
7
(2,304,978)
(2,315,183)
Net current liabilities
(1,869,910)
(1,571,334)
Total assets less current liabilities
(780,532)
(238,801)
Creditors: amounts falling due after more than one year
8
(79,473)
(69,444)
Net liabilities
(860,005)
(308,245)
Capital and reserves
Called up share capital
9
855
750
Profit and loss reserves
(860,860)
(308,995)
Total equity
(860,005)
(308,245)
The directors of the company have elected not to include a copy of the profit and loss account within the financial statements.true
These financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.
The financial statements were approved by the board of directors and authorised for issue on 15 September 2025 and are signed on its behalf by:
P Dunn
Director
Company Registration No. 10218146
HEALTHCALL SOLUTIONS LIMITED
NOTES TO THE FINANCIAL STATEMENTS
FOR THE PERIOD ENDED 31 MARCH 2025
- 2 -
1
Accounting policies
Company information
Healthcall Solutions Limited is a private company limited by shares incorporated in England and Wales. The registered office is Northumbria House Silver Fox Way, Cobalt Business Park, Newcastle upon Tyne, England, NE27 0QJ.
1.1
Accounting convention
These financial statements have been prepared in accordance with FRS 102 “The Financial Reporting Standard applicable in the UK and Republic of Ireland” (“FRS 102”) and the requirements of the Companies Act 2006 as applicable to companies subject to the small companies regime. The disclosure requirements of section 1A of FRS 102 have been applied other than where additional disclosure is required to show a true and fair view.
The financial statements are prepared in sterling, which is the functional currency of the company. Monetary amounts in these financial statements are rounded to the nearest £.
The financial statements have been prepared under the historical cost convention. The principal accounting policies adopted are set out below.
1.2
Going concern
Atruet the time of approving the financial statements, the directors have a reasonable expectation that the company has adequate resources to continue in operational existence for the foreseeable future given the support of controlling party, Northumbria Healthcare Trust. Given the importance of the company's role in patient care in the region and the Trust's commitment to this service, the directors have an expectation that support will be available until the company becomes self-sufficient. Thus the directors continue to adopt the going concern basis of accounting in preparing the financial statements.
1.3
Reporting period
The accounts have been prepared for the 15 month period to March 2025 therefore the comparative amounts presented in the financial statements for the year ended 31 December 2023, including related notes, are not entirely comparable.
1.4
Turnover
Turnover represents amounts receivable from the company's principal activities and is recognised net of value added tax.
1.5
Intangible fixed assets other than goodwill
Intangible assets acquired separately from a business are recognised at cost and are subsequently measured at cost less accumulated amortisation and accumulated impairment losses.
Amortisation is recognised so as to write off the cost or valuation of assets less their residual values over their useful lives on the following bases:
Software development
over 3 years
1.6
Tangible fixed assets
Tangible fixed assets are initially measured at cost and subsequently measured at cost or valuation, net of depreciation and any impairment losses.
HEALTHCALL SOLUTIONS LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE PERIOD ENDED 31 MARCH 2025
1
Accounting policies
(Continued)
- 3 -
Depreciation is recognised so as to write off the cost or valuation of assets less their residual values over their useful lives on the following bases:
Fixtures and fittings
33% straight line
IT equipment
33% straight line
1.7
Impairment of fixed assets
At each reporting period end date, the company reviews the carrying amounts of its tangible and intangible assets to determine whether there is any indication that those assets have suffered an impairment loss. If any such indication exists, the recoverable amount of the asset is estimated in order to determine the extent of the impairment loss (if any).
1.8
Stocks
Stocks are stated at the lower of cost and estimated selling price less costs to complete and sell.
1.9
Financial instruments
The company has elected to apply the provisions of Section 11 ‘Basic Financial Instruments’ and Section 12 ‘Other Financial Instruments Issues’ of FRS 102 to all of its financial instruments.
Financial instruments are recognised in the company's balance sheet when the company becomes party to the contractual provisions of the instrument.
Basic financial assets
Basic financial assets, which include debtors and cash and bank balances, are initially measured at transaction price including transaction costs and are subsequently carried at amortised cost.
Classification of financial liabilities
Financial liabilities and equity instruments are classified according to the substance of the contractual arrangements entered into. An equity instrument is any contract that evidences a residual interest in the assets of the company after deducting all of its liabilities.
Basic financial liabilities
Basic financial liabilities, including creditors and loans, are initially recognised at transaction price unless the arrangement constitutes a financing transaction, where the debt instrument is measured at the present value of the future payments discounted at a market rate of interest. Financial liabilities classified as payable within one year are not amortised.
Debt instruments are subsequently carried at amortised cost, using the effective interest rate method.
Trade creditors are obligations to pay for goods or services that have been acquired in the ordinary course of business from suppliers. Amounts payable are classified as current liabilities if payment is due within one year or less. If not, they are presented as non-current liabilities. Trade creditors are recognised initially at transaction price and subsequently measured at amortised cost using the effective interest method.
HEALTHCALL SOLUTIONS LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE PERIOD ENDED 31 MARCH 2025
1
Accounting policies
(Continued)
- 4 -
1.10
Taxation
The tax expense represents the sum of the tax currently payable and deferred tax.
Current tax
The tax currently payable is based on taxable profit for the year. Taxable profit differs from net profit as reported in the profit and loss account because it excludes items of income or expense that are taxable or deductible in other years and it further excludes items that are never taxable or deductible. The company’s liability for current tax is calculated using tax rates that have been enacted or substantively enacted by the reporting end date.
Deferred tax
Deferred tax liabilities are generally recognised for all timing differences and deferred tax assets are recognised to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits. Such assets and liabilities are not recognised if the timing difference arises from goodwill or from the initial recognition of other assets and liabilities in a transaction that affects neither the tax profit nor the accounting profit.
1.11
Retirement benefits
Payments to defined contribution retirement benefit schemes are charged as an expense as they fall due.
2
Employees
The average monthly number of persons (including directors) employed by the company during the period was:
2025
2023 - unaudited
Total
18
23
HEALTHCALL SOLUTIONS LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE PERIOD ENDED 31 MARCH 2025
- 5 -
3
Intangible fixed assets
Software development
£
Cost
At 1 January 2024
1,463,030
Additions
485,274
Disposals
(21,811)
At 31 March 2025
1,926,493
Amortisation
At 1 January 2024
132,031
Amortisation charged for the period
705,085
At 31 March 2025
837,116
Carrying amount
At 31 March 2025
1,089,377
At 31 December 2023
1,330,999
4
Tangible fixed assets
Fixtures and fittings
IT equipment
Total
£
£
£
Cost
At 1 January 2024 and 31 March 2025
2,350
17,492
19,842
Depreciation
At 1 January 2024
1,485
16,824
18,309
Depreciation charged in the period
865
668
1,533
At 31 March 2025
2,350
17,492
19,842
Carrying amount
At 31 March 2025
At 31 December 2023
865
668
1,533
5
Fixed asset investments
2025
2023 - unaudited
£
£
Shares in group undertakings and participating interests
1
1
HEALTHCALL SOLUTIONS LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE PERIOD ENDED 31 MARCH 2025
- 6 -
6
Debtors
2025
2023 - unaudited
Amounts falling due within one year:
£
£
Trade debtors
55,226
95,280
Corporation tax recoverable
5,759
Other debtors
59,895
37,341
Prepayments and accrued income
87,911
288,252
203,032
426,632
7
Creditors: amounts falling due within one year
2025
2023 - unaudited
£
£
Other borrowings
1,515,416
Trade creditors
383,734
401,308
Corporation tax
39,569
Other taxation and social security
47,482
40,186
Deferred income
222,520
1,827,647
Other creditors
1
1
Accruals and deferred income
96,256
46,041
2,304,978
2,315,183
Other borrowings are secured by way of fixed and floating charges over the assets of the company and interest is charged at 4% over base rate.
8
Creditors: amounts falling due after more than one year
2025
2023 - unaudited
£
£
Deferred income
79,473
69,444
HEALTHCALL SOLUTIONS LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE PERIOD ENDED 31 MARCH 2025
- 7 -
9
Called up share capital
2025
2023 - unaudited
Ordinary share capital
£
£
Issued and fully paid
Ordinary shares of £1 each
750
Ordinary A shares of £1 each
850
Ordinary B shares of £1 each
5
855
750
During the period an additional 100 £1 Ordinary shares were issued at par value. The entire share capital was then redesignated as Ordinary A shares. At the same time, 5 £1 Ordinary B shares were issued at par value.
Each Ordinary A and B share has the right to a vote at general meetings, entitled to receive dividends declared and the right to any distribution arising from the net proceeds of sale in accordance with the Articles.
10
Operating lease commitments
Lessee
At the reporting end date the company had outstanding commitments for future minimum lease payments under non-cancellable operating leases, as follows:
2025
2023 - unaudited
£
£
Total commitments
12,655
43,793
11
Related party transactions
The following amounts were outstanding at the reporting end date:
2025
2023 - unaudited
Amounts due to related parties
£
£
Entities with control, joint control or significant influence over the company
1,515,416
-
HEALTHCALL SOLUTIONS LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE PERIOD ENDED 31 MARCH 2025
- 8 -
12
Audit report information
As the income statement has been omitted from the filing copy of the financial statements, the following information in relation to the audit report on the statutory financial statements is provided in accordance with s444(5B) of the Companies Act 2006.
The auditor's report is unqualified and includes the following:
Opinion
In our opinion the financial statements:
give a true and fair view of the state of the company's affairs as at 31 March 2025 and of its loss for the period then ended;
have been properly prepared in accordance with United Kingdom Generally Accepted Accounting Practice; and
have been prepared in accordance with the requirements of the Companies Act 2006.
Senior Statutory Auditor:
Maxine Pott
Statutory Auditor:
Sumer Auditco Limited
Date of audit report:
15 September 2025
2025-03-312024-01-01falsefalsefalse15 September 2025CCH SoftwareCCH Accounts Production 2025.200No description of principal activityCN BlackID DoveNC HutchinsonF DinC GrahamP DunnD ElliottV McFarlane-ReidJ ReedRJ Leonard102181462024-01-012025-03-31102181462025-03-31102181462023-12-3110218146core:Non-standardIntangibleAssetClass1ComponentIntangibleAssetsOtherThanGoodwill2025-03-3110218146core:Non-standardIntangibleAssetClass1ComponentIntangibleAssetsOtherThanGoodwill2023-12-3110218146core:FurnitureFittings2025-03-3110218146core:ComputerEquipment2025-03-3110218146core:FurnitureFittings2023-12-3110218146core:ComputerEquipment2023-12-3110218146core:CurrentFinancialInstrumentscore:WithinOneYear2025-03-3110218146core:CurrentFinancialInstrumentscore:WithinOneYear2023-12-3110218146core:CurrentFinancialInstruments2025-03-3110218146core:CurrentFinancialInstruments2023-12-3110218146core:Non-currentFinancialInstruments2025-03-3110218146core:Non-currentFinancialInstruments2023-12-3110218146core:ShareCapital2025-03-3110218146core:ShareCapital2023-12-3110218146core:RetainedEarningsAccumulatedLosses2025-03-3110218146core:RetainedEarningsAccumulatedLosses2023-12-3110218146core:ShareCapitalOrdinaryShareClass12025-03-3110218146core:ShareCapitalOrdinaryShareClass12023-12-3110218146core:ShareCapitalOrdinaryShareClass22025-03-3110218146core:ShareCapitalOrdinaryShareClass22023-12-3110218146core:ShareCapitalOrdinaryShareClass32025-03-3110218146core:ShareCapitalOrdinaryShareClass32023-12-3110218146core:ShareCapitalOrdinaryShares2025-03-3110218146core:ShareCapitalOrdinaryShares2023-12-3110218146bus:Director62024-01-012025-03-3110218146core:IntangibleAssetsOtherThanGoodwill2024-01-012025-03-3110218146core:Non-standardIntangibleAssetClass1ComponentIntangibleAssetsOtherThanGoodwill2024-01-012025-03-3110218146core:FurnitureFittings2024-01-012025-03-3110218146core:ComputerEquipment2024-01-012025-03-31102181462023-01-012023-12-3110218146core:Non-standardIntangibleAssetClass1ComponentIntangibleAssetsOtherThanGoodwill2023-12-3110218146core:FurnitureFittings2023-12-3110218146core:ComputerEquipment2023-12-31102181462023-12-3110218146bus:OrdinaryShareClass12024-01-012025-03-3110218146bus:OrdinaryShareClass22024-01-012025-03-3110218146bus:OrdinaryShareClass32024-01-012025-03-3110218146core:EntitiesWithJointControlOrSignificantInfluenceOverReportingEntity2025-03-3110218146bus:PrivateLimitedCompanyLtd2024-01-012025-03-3110218146bus:FRS1022024-01-012025-03-3110218146bus:Audited2024-01-012025-03-3110218146bus:Director12024-01-012025-03-3110218146bus:Director22024-01-012025-03-3110218146bus:Director32024-01-012025-03-3110218146bus:Director42024-01-012025-03-3110218146bus:Director52024-01-012025-03-3110218146bus:Director72024-01-012025-03-3110218146bus:Director82024-01-012025-03-3110218146bus:Director92024-01-012025-03-3110218146bus:Director102024-01-012025-03-3110218146bus:SmallCompaniesRegimeForAccounts2024-01-012025-03-3110218146bus:FullAccounts2024-01-012025-03-31xbrli:purexbrli:sharesiso4217:GBP